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Background: Nonsyndromic orofacial cleft is a common birth defect with a complex etiology, including multiple
genetic and environmental risk factors. Recent whole genome analyses suggested associations between
nonsyndromic orofacial cleft and up to 18 genetic risk loci (ABCA4, BMP4, CRISPLD2, GSTT1, FGF8, FGFR2, FOXE1, IRF6,
MAFB, MSX1, MTHFR, MYH9, PDGFC, PVRL1, SUMO1, TGFA, TGFB3, and VAX1), each of which confers a different relative
risk in different populations. We evaluate the nonsynonymous variants in these 18 genetic risk loci in nonsyndromic
orofacial clefts and normal controls to clarify the specific variants in Taiwanese population.
Methods: We evaluated these 18 genetic risk loci in 103 cases of nonsyndromic orofacial clefts and 100
normal controls using a next-generation sequencing (NGS) customized panel and manipulated a whole-exon
targeted-sequencing study based on the NGS system of an Ion Torrent Personal Genome Machine (IT-PGM).
IT-PGM data processing, including alignment with the human genome build 19 reference genome (hg19),
base calling, trimming of barcoded adapter sequences, and filtering of poor signal reads, was performed
using the IT platform-specific pipeline software Torrent Suite, version 4.2, with the plug-in “variant caller”
program. Further advanced annotation was facilitated by uploading the exported VCF file from Variant Caller
to the commercial software package Ion Reporter; the free online annotation software Vanno and Mutation
Taster. Benign or tolerated amino acid changes were excluded after analysis using sorting intolerant from
tolerant and polymorphism phenotyping. Sanger sequencing was used to validate the significant variants
identified by NGS. Furthermore, each variant was confirmed in asymptomatic controls using the Sequenom
MassARRAY (San Diego, CA, USA).
Results: We identified totally 22 types of nonsynonymous variants specific in nonsyndromic orofacial clefts,
including 19 single nucleotide variants, 2 deletions, and 1 duplication in 10 studied genes(ABCA4, MYH9,
MTHFR, CRISPLD2, FGF8, PVRL1, FOXE1, VAX1, FGFR2, and IRF6). Nonsynonymous variants in MYH9 and ABCA4,
which were detected in 6 and 5 individuals, respectively, were identified to be the most frequent risk loci in
nonsyndromic orofacial clefts in the Taiwanese population.
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Conclusions: Nonsynonymous variants in MYH9 and ABCA4 were identified to be the most frequent risk loci
in nonsyndromic orofacial clefts in the Taiwanese population. These findings in our study have provided
additional information regarding specific variants associated with nonsyndromic orofacial clefts in different
population and demonstrate the power of our customized NGS panel, which is clinically useful for the
simultaneous detection of multiple genes associated with nonsyndromic orofacial clefts.
Keywords: Nonsyndromic orofacial clefts, Next-generation sequencing, MYH9, ABCA4Background
Nonsyndromic orofacial clefts, which include cleft lip
with or without cleft palate (CL/P) and isolated cleft
palate (CPI), are among the most common congenital
malformations worldwide. The prevalence of this major
birth defect widely ranges from 1/700 to 1/1000, with
fluctuations attributed to different areas and ethnicities
[1, 2]. Epidemiological data reveal that the prevalence of
nonsyndromic CL/P is lowest among African populations
(0.4/1000), intermediate among European populations (1/
1000), and highest among Asian populations (2/1000) [3].
Nonsyndromic orofacial cleft is not only associated with
increased infant morbidity and mortality but also has
enormous effects on speech, hearing, appearance, and
mental disability, thereby increasing long-term medical
costs and placing substantive burdens on families and
societies [4, 5].
Nonsyndromic orofacial cleft is an etiologically hetero-
geneous disease with multiple genetic and environmental
risk factors [6]. Maternal smoking, alcohol consumption,
and folate and vitamin deficiencies, particularly during the
first trimester of pregnancy, have been suggested to
increase the occurrence of nonsyndromic CL/P [7, 8]. Pre-
vious gene identification studies of nonsyndromic CL/P
were generally based on genome-wide association studies
(GWASs) [9–12], genome-wide linkage studies [13], and
GWAS meta-analyses [14, 15]. These studies identified
genetic risk loci associated with nonsyndromic CL/P on
chromosomes 1p22, 1p36, 2p21, 3p11.1, 8q21.3, 8q24,
9q22, 10q25, 15q22, 17p13, 17q22, and 20q12.
Although GWAS studies have identified multiple non-
syndromic CL/P-associated genetic loci, further progress in
the identification of casual variants has been limited be-
cause these approaches focus on common variants and
neglect low-frequency variants [16]. To identify novel and
low-frequency variants, next-generation sequencing (NGS)-
based techniques facilitate the simultaneous detection of
causal variants in large genomic regions. We selected 18
nonsyndromic orofacial cleft-related candidate genes,
including ABCA4, BMP4, CRISPLD2, GSTT1, FGF8,
FGFR2, FOXE1, IRF6, MAFB, MSX1, MTHFR, MYH9,
PDGFC, PVRL1, SUMO1, TGFA, TGFB3, and VAX1, based
on previous associated studies [7, 17] to conduct a custom-
ized NGS panel and subsequently manipulated a whole-exon targeted-sequencing study based on the NGS system
of an Ion Torrent Personal Genome Machine (IT-PGM). A
total of 103 patients with nonsyndromic orofacial clefts and
100 independent asymptomatic normal controls were
enrolled to investigate potential variants associated with
nonsyndromic orofacial clefts and identify specific nonsy-
nonymous variants in Taiwanese population.Methods
Case enrollment and ethics statement
The study population included 103 Taiwanese patients
with isolated, nonsyndromic orofacial clefts recruited from
the Linkou Chang Gung Memorial Hospital from 1995 to
2014; patients’ diagnoses had been confirmed via neonatal
photographs or chart descriptions written by plastic
surgeons or clinical geneticists. Individuals with other
systemic abnormalities, developmental or mental delays,
and confirmed chromosomal abnormalities were excluded
from this study. For the control group, we recruited 100
asymptomatic Taiwanese volunteers who had no family
history of orofacial clefts from among the employees of
Linkou Chang Gung Memorial Hospital.
This study was approved by the institutional review
board (IRB 101-4637A3) at Linkou Chang Gung memor-
ial hospital, and written informed consent was obtained
from all adult participants and the parents or guardians
of pediatric participants.Sample collection and genomic DNA preparation
Genomic DNA was extracted from 10-ml peripheral
blood samples using the QIAamp DNA Blood Mini Kit
(Qiagen, Valencia, CA, USA) as follows: 20 μL of QIA-
GEN Protease (or protease K) was mixed with 200 μL
of buffy coat via a 15-s vortex step. The mixture was then
incubated at 56 °C for 10 min after adding 200 μL of
Buffer AL. Next, 200 μL of 96–100 % ethanol was added,
followed by a 15-s vortex and transfer to a QIAamp Mini
spin column. The silica membrane was washed via centri-
fugation with Buffers AW1 and AW2. Genomic DNA was
eluted with Buffer AE, and the quantity and quality were
determined using a Nanodrop (Thermo Fisher Scientific,
Waltham, MA, USA) and Qubit 2.0 fluorometer (Life
Technologies, Carlsbad, CA, USA).
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orofacial cleft
We analyzed 18 genetic loci associated with the risk of
nonsyndromic orofacial cleft, including IRF6, VAX1,
ABCA4, BMP4, FGFR2, FOXE1, MAFB, MSX1, MYH9,
CRISPLD2, FGF8, GSTT1, MTHFR, PDGFC, PVRL1,
SUMO1, TGFA, and TGFB3 (Table 1). We used the
Ion AmpliSeq™ Designer v2.2.1 cloud-based software
program, which was supplied free of charge by Life
Technologies, to design our customized panel. Moreover,
we used the National Center for Biotechnology Informa-
tion (NCBI) ClinVar database to identify pathogenic
variants in these 18 genes and set up a hotspot database.
IT-PGM AmpliSeq library preparation and IT-PGM
sequencing
AmpliSeq multiplexed libraries were constructed using
the Ion AmpliSeq Library Kit 2.0 according to the man-
ufacturer’s protocol (Life Technologies, Part #4475345),
with some modifications. The preparation was started
with 30 ng of genomic DNA in a volume of ≤6 μL; the
501 amplicons were amplified by PCR and divided into
two primer pools. We increased the annealing and
extension steps of PCR program from 4 to 8 min to
improve the efficiency of longer amplicons. Primer
sequences were partially digested with FuPa reagent, and
barcoded adapters were ligated with DNA ligase. Follow-





















VAX1 9781 10q25.3(Beckman Coulter, Brea, CA, USA), the prepared library
was quantified using a Qubit 2.0 Fluorometer (Life
Technologies) and Bioanalyzer high-sensitivity DNA
chip (Agilent Technologies Inc., Santa Clara, CA, USA).
Quantified libraries were pooled and diluted further to
generate a 10-pmol/L working stock. To clonally amplify
library DNA onto IonSpheres (ISPs), we used emulsion
PCR, emulsion breaking, and template enrichment using
the Ion OneTouch™ 200 system and Template Kit v2.0
(Life Technologies) according to the manufacturer’s pro-
tocols. Enriched ISPs were prepared for sequencing
using the Ion PGM 200 Sequencing Kit v2.0 and loaded
on an Ion 316 chip v2 or Ion 318 chip v2, depending on
whether 7 or 14 samples were to be sequenced, respect-
ively. To sequence an authentic variant, an ideal average
coverage for each amplicon of 500× and variant fre-
quency of at least 5 % in the wild-type background were
used in this study.
Bioinformatics analysis
IT-PGM data processing, including alignment with the
human genome build 19 reference genome (hg19), base
calling, trimming of barcoded adapter sequences, and
filtering of poor signal reads, was performed using the
IT platform-specific pipeline software Torrent Suite, ver-
sion 4.2, with the plug-in “variant caller” program (Life
Technologies). Further advanced annotation was facili-
tated by uploading the exported VCF file from Variantomic orofacial clefts and normal controls
Protein
ATP-binding cassette, sub-family A, member 4
Bone morphogenetic protein 4
Cysteine-rich secretory protein LCCL domain containing 2
Glutathione S-transferase theta 1
Fibroblast growth factor 8
Fibroblast growth factor receptor 2
Forkhead box E1
Interferon regulatory factor 6




Myosin, heavy chain 9
Platelet derived growth factor C
Poliovirus receptor-related 1
Small ubiquitin-like modifier 1
Transforming growth factor, alpha
Transforming growth factor, beta 3
Ventral anterior homeobox 1
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(Life Technologies); the free online annotation software
Vanno [18] and MutationTaster. Benign or tolerated
amino acid changes were excluded after analysis using
sorting intolerant from tolerant (SIFT) and polymorph-
ism phenotyping (PolyPhen). In addition, we used the
Integrative Genomics Viewer to visualize the status of
each read alignment and the presence of variants from
the reference genome to clarify possible strand biases or
sequencing errors.Experimental validation
Validation by alternative sequencing methods was required
for NGS-identified variants that passed the in-house filter-
ing steps. Sanger sequencing was used to validate the
significant variants identified by NGS. Furthermore, each
variant was confirmed in asymptomatic controls using the
Sequenom MassARRAY (San Diego, CA, USA).Results
Cases
The clinical features of the 103 patients with nonsyn-
dromic orofacial clefts and 100 normal controls are listed
in Table 2.Customized NGS panel for nonsyndromic orofacial cleft
Detailed information about this customized panel is listed
in Additional file 1: Table S1. This panel comprises 501
amplicons divided into two primer pools: 254 amplicons
in primer pool 1 and 247 amplicons in primer pool 2. The
amplicon sizes are 125–275 bp. Details regarding the
numbers of exons and amplicons in the 18 selected genes
are listed in Additional file 1: Table S2. The average target
region coverage rate was 94.09 %.Table 2 Clinical characteristics of patients with nonsyndromic




Number (%) Number (%)
Gender Male 48 (46.6 %) 45 (45.0 %)
Female 55 (53.4 %) 55 (55.0 %)
Age Range 1–41 21–58
Cleft type Cleft lip only 12 (11.6 %) absent
Cleft palate only 32 (31.0 %) absent
Cleft lip and palate 56 (54.4 %) absent
Unclassified 3 (3.0 %) absent
Cleft site Unilateral 53 (51.4 %) absent
Bilateral 46 (44.7 %) absent
Unclassified 4 (3.9 %) absentPerformance of the customized NGS panel
Our quality control standard for defining a true variant
is a gene locus coverage depth >50×. In other words, the
average coverage depth of each amplicon should receive
more than 50× reads to reduce the risk of misjudgment
in subsequent PGM sequencing. Figure 1 shows the
average coverage depths of the 501 amplicons in the 203
evaluated samples (103 nonsyndromic orofacial cleft and
100 normal control samples); 95 % of amplicons had a
gene locus coverage depth >50 × .All nonsynonymous variants in patients with
nonsyndromic orofacial clefts
The distributions of all nonsynonymous variants of the
18 analyzed genes among patients with nonsyndromic
orofacial clefts are shown in Additional file 1: Table S3.
We identified 29 types of nonsynonymous variants,
including 23 single nucleotide variants, 4 deletions, 1
duplication, and 1 insertion.All nonsynonymous variants in normal controls
The distributions of all nonsynonymous variants of the
18 analyzed genes among normal controls are shown in
Additional file 1: Table S4. We identified 15 types of
nonsynonymous variants, including 12 single nucleotide
variants, 2 deletions, and 1 insertion.Specific nonsynonymous variants in patients with
nonsyndromic orofacial cleft
A comparison of nonsynonymous variants between pa-
tients with nonsyndromic orofacial clefts and normal
controls identified 22 types of specific variants within 10
studied genes in the former group (Table 3). Among
these, 19 were single-nucleotide variants (in ABCA4,
MYH9, MTHFR, CRISPLD2, FGF8, PVRL1, FOXE1, and
FGFR2), 2 were deletions (in CRISPLD2 and IRF6), and
1 was a duplication (VAX1). The nonsynonymous vari-
ants in MYH9 and ABCA4, which affected 6 and 5 indi-
viduals with nonsynonymous variants, respectively, were
the most frequent risk loci among this Taiwanese popu-
lation. The distributions of nonsynonymous variants in
MYH9 and ABCA4 are shown in Fig. 2.
It is worth noticing that in our population, no nonsy-
nonymous variants were found in eight genes (BMP4,
GSTT1, MAFB, MSX1, PDGFC, SUMO1, TGFA, and
TGFB3). These eight genes appear to have a weaker
association with nonsyndromic orofacial cleft in the
Taiwanese population. As most hotspot variants in the
NCBI database were previously collected from foreign
populations, our findings may reflect specific variants
associated with nonsyndromic orofacial cleft in the
Taiwanese population.
Fig. 1 Nonsyndromic orofacial clefts customized next-generation sequencing panel performance with an average coverage depth of 501 amplicons
Table 3 Specific variants found to be associated with nonsyndromic orofacial cleft
Gene Coding Amino acid change PolyPhen SIFT Mutation Taster Phenotype Number of cases
MTHFR c.1816C > T p.R606C Possibly damaging Damaging Disease causing BL CLP 1/103
MTHFR c.62G > A p.S21N Benign Damaging Disease causing BL CP 1/103
MYH9 c.5722G > A p.D1908N Possibly damaging Damaging Disease causing L CLP 1/103
MYH9 c.3676C > T p.R1226W Benign Damaging Disease causing L CLP 1/103
MYH9 c.3320G > A p.R1107Q Possibly damaging Damaging Disease causing BL CP 1/103
MYH9 c.3262G > A p.A1088T Possibly damaging Damaging Disease causing R CL 1/103
MYH9 c.2606C > T p.T869M Benign Damaging Polymorphism BL CP 1/103
MYH9 c.452A > G p.Y151C Possibly damaging Damaging Disease causing L CLP 1/103
CRISPLD2 c.119_121del p.40_41del — — Polymorphism L CLP 1/103
CRISPLD2 c.1337C > G p.A446G Possibly damaging Damaging Disease causing L CLP 1/103
ABCA4 c.6498C > G p.I2166M Possibly damaging Tolerated Disease causing R CLP 1/103
ABCA4 c.4610C > T p.T1537M Possibly damaging Damaging Disease causing L CL; unknown CP 2/103
ABCA4 c.4297G > A p.V1433I Possibly damaging Tolerated Polymorphism BL CLP 1/103
ABCA4 c.763C > T p.R255C Possibly damaging Tolerated Disease causing L CL 1/103
FOXE1 c.1090G > A p.G364S Possibly damaging Tolerated Disease causing BL CLP 2/103
FGF8 c.251C > T p.P84L Possibly damaging Damaging Disease causing L CL 1/103
FGF8 c.250C > T p.P84S Possibly damaging Damaging Disease causing L CL 1/103
VAX1 c.363dupT p.C122fs — — Disease causing R CLP 1/103
PVRL1 c.334 T > A p.S112T Benign — Disease causing Unknown CLP 1/103
PVRL1 c.52C > T p.L18F Benign — Polymorphism R CLP; L CLP 2/103
FGFR2 c.293C > T p.T98M Possibly damaging Damaging Disease causing L CL 1/103
IRF6 c.421_423del p.141_141del — — Disease causing R CLP 1/103
BL bilateral, CL cleft lip, CLP cleft lip with palate, CP cleft palate, L left, R right
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Fig. 2 Distribution of nonsynonymous variants specific to orofacial clefts in MYH9 and ABCA4 (blue dots indicate the numbers of
affected individuals)
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Orofacial cleft is among the most common human
congenital malformations, affecting 135,000 neonates
worldwide each year [2]. Orofacial clefts have been asso-
ciated with both environmental and genetic risk factors
and the prevalence of this major birth defect widely
ranges among different areas and ethnicities.
In the last decade, major advances in the identification
of the causative genetic mutations underlying syndromic
forms of CL/P have revealed more than 60 syndromic
cleft-associated genes [19]. By contrast, the genetic cause
of nonsyndromic forms of CL/P remains mostly unclear.
The lack of progress in our understanding of the genetic
etiology of nonsyndromic CL/P is obviously associated
with the lack of a recognizable mode of inheritance and
reduced penetrance of these patients, as well as the low
rate of positive family history among affected persons [20].
With the advances in the genomic era, the recent develop-
ment of powerful and cost-effective genomic tools has
opened new routes for phenotyping nonsyndromic orofa-
cial clefts. Recent GWAS [9–12], genome-wide linkage
studies [13], and GWAS meta-analyses [14, 15] have
suggested that nonsyndromic orofacial clefts might be
associated with up to 18 genetic loci, each with a different
relative risk in different populations. These candidate
loci include IRF6 (1q32.3-q41),VAX1 (10q26.1), ABCA4
(1p22.1-p21), BMP4 (14q22-q23), FGFR2 (10q26), FOXE1
(9q22), MAFB (20q11,2-q13.1), MSX1 (4p16.3-p16.1),
MYH9 (22q13.1), CRISPLD2 (16q24.1), FGF8 (10q24),
GSTT1 (22q11.23), MTHFR (1p36.3), PDGFC (4q32),
PVRL1 (11q23.3), SUMO1 (2q33), TGFA (2p13), andTGFB3 (14q24) [19, 21–28]. These genetic risk loci carry
a different relative risk in different populations. Our study
is the first to analyze these 18 genetic loci associated with
nonsyndromic orofacial cleft in the Taiwanese population.
As nonsyndromic orofacial cleft is a complex condition
affected by multiple genes, genetic testing must be robust
and cover a wide spectrum of potential mutations. Unlike
traditional sequencing, which screens one gene at a time,
exon by exon, NGS techniques allow massive parallel
sequencing of as many genes as desired, thereby leveling
the economic and technological barriers to detecting
mutations on a genome-wide scale. Although this technol-
ogy is suitable for the detection of any mutation within a
rational target, targeted NGS is considered to be particu-
larly useful for detecting mutations in disorders with a
highly heterogeneous genetic background. With this
understanding, we used a customized NGS panel to rap-
idly detect possible variants in these 18 statistically vali-
dated candidate genes among patients with nonsyndromic
orofacial clefts.
In our study, we evaluated 18 genetic risk loci in 103
cases of nonsyndromic orofacial clefts and 100 normal
controls from the Taiwanese population using custom-
ized NGS, which revealed 22 types of specific variants
within 10 studied genes in individuals with nonsyn-
dromic orofacial clefts. Among these, 19 were single nu-
cleotide variants (in ABCA4, MYH9, MTHFR, CRISPLD2,
FGF8, PVRL1, FOXE1, and FGFR2), 2 were deletions (in
CRISPLD2 and IRF6 gene), and 1 was a duplication
(VAX1). The nonsynonymous variants in MYH9 and
ABCA4, which were detected in 6 and 5 individuals,
Peng et al. BMC Medical Genetics  (2016) 17:59 Page 7 of 8respectively, were the most frequent risk loci in our
Taiwanese population.
MYH9, or myosin heavy chain 9, has been shown to
associate with nonsyndromic CL/P in several popula-
tions [29]. Abundant, specific expression of MYH9 was
observed in the epithelial cells of palatal shelves prior to
fusion. The expression level of MYH9 was shown to
decrease and be restricted to epithelial triangles before
disappearing upon the completion of fusion [30]. In our
study,MYH9 is the most frequent risk loci in the Taiwanese
population, providing further evidence for the involvement
of MYH9 in the etiology of nonsyndromic CL/P.
A recent GWAS of several populations revealed
markers in/near the gene encoding ABCA4, indicating
a novel susceptibility locus for CL/P [9]. In Honduran
and Colombian populations, ABCA4 is a candidate
gene associated with nonsyndromic orofacial clefting
[31]. In the Brazilian population, ABCA4 rs540426 as-
sociated strongly with CL/P, unilateral and right CL/P,
and bilateral CL/P, whereas the SNP rs481931 exhib-
ited borderline associations with CL/P and bilateral CL/P
[32]. However, in a Chinese Han population, ABCA4 was
not found to associated with nonsyndromic orofacial clefts
[33]. In our study, several nonsynonymous variants in
ABCA4 were specifically found in individuals with non-
syndromic orofacial clefts from a Taiwanese population.
Conclusions
Nonsynonymous variants in MYH9 and ABCA4 were
identified to be the most frequent risk loci in nonsyn-
dromic orofacial clefts in the Taiwanese population. Our
findings provide us more information about specific
variants associated with nonsyndromic orofacial clefts in
different population, as well as demonstrate the power of
our customized NGS panel, which is clinically useful for
the simultaneous detection of multiple genes associated
with nonsyndromic orofacial clefts. Furthermore, recent
NGS studies have shown that fetal DNA from a few milli-
liters of maternal plasma is sufficient for fetal whole gen-
ome sequencing. Importantly, using parental genomes as
guides, fetal genome sequences could be scanned for mu-
tations prenatally and noninvasively [34, 35]. In the near
future, it will be possible to predict whether a fetus will be
affected by a nonsyndromic orofacial cleft based on a tar-
geted NGS-based investigation of genetic risk loci.Additional file
Additional file 1: Table S1. Customized NGS panel information for
nonsyndromic orofacial clefts. Table S2. Detailed panel information
about the 18 selected genes studied in nonsyndromic orofacial clefts.
Table S3. All nonsynonymous variants found in individuals with
nonsyndromic orofacial clefts. Table S4. All nonsynonymous variants
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